Daiichi Sankyo

Japanese pharmaceutical company

Logo of Daiichi Sankyo

Daiichi Sankyo Co., Ltd. is a global pharmaceutical company and one of the largest in Japan. It was established in 2005 through the merger of two companies, Daiichi Pharmaceutical and Sankyo Co., Ltd. The company is headquartered in Tokyo, Japan, and is known for its research and development in the field of cardiovascular disease, oncology, and immunology.

History

Daiichi Sankyo was formed in 2005, but its roots trace back to the early 20th century. Sankyo Co., Ltd. was founded in 1899, and Daiichi Pharmaceutical was established in 1915. Both companies played significant roles in the development of the Japanese pharmaceutical industry.

Merger

The merger of Daiichi Pharmaceutical and Sankyo Co., Ltd. was driven by the need to compete on a global scale and to pool resources for more effective research and development. The merger created a company with a strong portfolio of products and a robust pipeline of new drugs.

Research and Development

Daiichi Sankyo is heavily invested in R&D and has several research facilities around the world. The company's research focuses on three main areas:

• Cardiovascular Disease: Developing treatments for hypertension, hyperlipidemia, and other cardiovascular conditions.
• Oncology: Focusing on innovative therapies for various types of cancer.
• Immunology: Researching treatments for autoimmune diseases and other immune-related conditions.

Products

Daiichi Sankyo offers a wide range of pharmaceutical products. Some of its well-known products include:

• Olmesartan: An antihypertensive medication used to treat high blood pressure.
• Edoxaban: An anticoagulant used to prevent stroke and venous thromboembolism.
• Prasugrel: An antiplatelet drug used to prevent blood clots in patients with acute coronary syndrome.

Global Presence

Daiichi Sankyo operates in over 20 countries and has a strong presence in the United States, Europe, and Asia. The company collaborates with various international partners to enhance its global reach and to bring innovative therapies to patients worldwide.

Corporate Social Responsibility

Daiichi Sankyo is committed to corporate social responsibility (CSR) and sustainability. The company focuses on improving access to healthcare, reducing its environmental impact, and supporting community initiatives.

Related pages

• Pharmaceutical industry
• List of pharmaceutical companies
• Drug development